Status:
COMPLETED
Optimizing Continuous-flow Left Ventricular Assist Device Settings and Identification of Pump Malfunction - A Comparative Study of Echocardiography and Invasive Hemodynamics
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Heart Failure.
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the trial is to identify factors which can be used as guidance when optimizing continuous-flow left ventricular assist device (CF-LVAD) settings. The hypothesis of the study is that pu...
Eligibility Criteria
Inclusion
- Heart failure patients with HeartMate II (HM II) followed as outpatients at The Heart Centre at University Hospital of Copenhagen, Rigshospitalet.
- Age \> 18 years.
- Heart failure in stable phase without the need for intravenous inotropic therapy.
- Ischemic or non-ischemic cardiomyopathy.
- Signed informed consent.
Exclusion
- Unstable patients with the need for intravenous inotropic therapy.
- Current hospitalization.
- Implantation of HM II less than one month ago.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01851889
Start Date
April 1 2013
End Date
October 1 2015
Last Update
October 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Rigshospitalet.
Copenhagen, Kbh Oe, Denmark, 2100